A carregar...
Radioiodine Therapy of Graves' Disease and the Uptake Paradox
PURPOSE OF THE STUDY: Radioiodine ((131)I) therapy is approved and well-accepted modality for the treatment of hyperthyroidism. The dosage of (131)I for successful treatment is based on many factors; however, an objective tool to determine the dose was missing. In a retrospective study, we found tha...
Na minha lista:
| Publicado no: | Indian J Nucl Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6958960/ https://ncbi.nlm.nih.gov/pubmed/31949364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijnm.IJNM_158_19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|